Patient organizations
The clinical trial, named EPIPSORA is an observational study to develop and validate an epigenetic biomarker panel that can predict treatment success in RA and PsO patients.
The EPIPSORA Observational Study has started in 2024 in various European hospitals in The Netherlands, Belgium and Portugal, and will take 3 years to complete. 200 patients will participate in the trial.
Video-podcasts
More information on the EPIPSORA study is given in the video podcast with subtitles in Dutch, French and Portugues:
The below patient organizations are active in the 3 countries where the EPIPSORA trial will be carried out.
